Sort by
Refine Your Search
-
Education Institutions, as amended. We offer: the backing of a prestigious and successful institution, a motivating and friendly environment, support for professional and personal development, opportunities
-
develop technologies and biotechnologies to break them down. http://www.recetox.muni.cz/en/career/career-at-recetox The PhD student will be employed in Loschmidt Laboratories , one of the leading protein
-
to development of hematological malignancies Department: Institute of Medical Genetics and Genomics Description: Hematological malignancies are closely related to various types of somatic mutations in blood cells
-
on immune cells and hematological malignancies. We aim to understand how changes in genome structure and regulation contribute to the development and progression of leukemia. Our new teammate will be
-
, to study various aspects of Fibroblast Growth Factor (FGF) signaling in disease. Current focus is on non-canonical FGF signaling pathways, differential signaling of FGF-receptors, and development
-
Department: Jan Křivánek Research Group: Dental Development and Regeneration – Faculty of Medicine Deadline: 31 Jan 2026 Start date: April 2026 or upon agreement Job type: full-time Job field
-
regulator of embryonic development as well as tissue homeostasis. While the complete absence of cilia is considered incompatible with life, even subtle defects in their assembly or function can trigger
-
Department: Dáša Bohačiaková Research Group: Neurobiology of the Development and Disease – Faculty of Medicine Deadline: 31 Jan 2026 Start date: April 2026 or upon agreement Job type: full-time Job
-
on understanding the molecular mechanisms behind retinal development and disease using human pluripotent stem cells. We specialize in creating retinal organoids, “eye-like” organoids, and other retinal cell types
-
: The research group of prof. Michal Masařík is a biomedical laboratory dedicated to exploring the molecular mechanisms that drive cancer progression, with a particular emphasis on the tumour microenvironment (TME